We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SMFT3:BMFBOVESPASmartfit Escola de Ginastica e Danca SA Analysis

Data as of 2026-03-15 - not real-time

R$18.18

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Smartfit's shares sit at R$18.18, well below the 20‑day (R$19.92), 50‑day (R$21.34) and 200‑day (R$23.48) moving averages, signaling a bearish technical stance, while the RSI of 27.9 places the stock in oversold territory and the MACD remains bearish.
Fundamentally, the company delivers strong top‑line growth (26.5% YoY), solid margins (gross 42.5%, operating 23.4%) and an attractive dividend yield of 8.14%, yet its balance sheet is heavily leveraged (debt‑to‑equity > 240) and free cash flow is slightly negative, creating sustainability concerns. The DCF fair value of R$72.1 implies a ~76% upside, analysts rate it a strong buy with a median target of R$32, and the forward PE of 8.4 suggests earnings acceleration. Despite high volatility (30% 30‑day) and decreasing volume, the low beta (0.44) tempers market‑wide risk, making the stock a compelling value play if the debt burden can be managed.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Oversold RSI indicating potential near‑term bounce
  • High dividend yield offering immediate income
  • Technical price well below key moving averages creating a discount entry

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Robust revenue growth and expanding footprint across Latin America
  • Forward earnings expansion reflected in a low forward PE of 8.4
  • Analyst consensus (13 analysts) strongly supportive with a median target of R$32

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF valuation indicates ~76% upside potential
  • Brand strength and digital fitness platform positioning for sustained growth
  • Opportunity to improve leverage as cash flow stabilizes

Key Metrics & Analysis

Financial Health

Revenue Growth26.50%
Profit Margin8.82%
P/E Ratio19.1
ROE11.51%
ROA5.31%
Debt/Equity242.81
P/B Ratio1.9
Op. Cash FlowR$2.1B
Free Cash FlowR$-13216000

Technical Analysis

TrendBearish
RSI27.9
SupportR$0.00
ResistanceR$21.96
MA 20R$19.92
MA 50R$21.34
MA 200R$23.48
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair ValueR$72.11
Target PriceR$32.12
Upside/Downside76.65%
GradeUndervalued
TypeBlend
Dividend Yield8.14%

Risk Assessment

Beta0.44
Volatility30.42%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.